Mckesson . Potential to keep going. Profitability still there.McKesson CorporationBATS:MCKMRCMMMCK remains a compelling healthcare compounder, supported by its dominant pharmaceutical distribution position. Accelerating oncology and specialty growth, strong free cash flow and aggressive buybacks.